BioNTech Jan 14, 2026 JPM26: BioNTech gears up for multiproduct oncology status by 2030 - Clinical Trials Arena
Endpoints News Dec 9, 2025 #SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer